Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression

Cancer Letters

Volumn 293, Issue 2, 2010, Pages 189-197

  Zhang, Yang ^a   Gong, Li hua ^a   Zhang, Hong quan ^a   Du, Qiang ^a   You, Jiang feng ^a   Tian, Xin xia ^a   Fang, Wei gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

ATP; Invasion; MMP; Prostate cancer; Rho GTPase

Indexed keywords

ADENOSINE TRIPHOSPHATE; COLLAGENASE 3; MATRIX METALLOPROTEINASE; PROTEIN CDC42; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STROMELYSIN; MMP13 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; RAC1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FILOPODIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; LAMELLIPODIUM; MALE; MICROENVIRONMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; CELL MOTION; DRUG EFFECT; EXTRACELLULAR SPACE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; PSEUDOPODIUM; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

ADENOSINE TRIPHOSPHATE; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR SPACE; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PSEUDOPODIA; RAC1 GTP-BINDING PROTEIN; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77952471484     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.01.010     Document Type: Article

References (42)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics. CA: Cancer J. Clin. 2009, 59:225-249.
2. Denmeade S.R., Isaacs J.T. A history of prostate cancer treatment. Nat. Rev. Cancer 2002, 2:389-396.
3. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006, 12:895-904.
4. Deli T., Csernoch L. Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. Pathol. Oncol. Res. 2008, 14:219-231.
5. Selzner N., Selzner M., Graf R., Ungethuem U., Fitz J.G., Clavien P.A. Water induces autocrine stimulation of tumor cell killing through ATP release and P2 receptor binding. Cell Death Differ. 2004, 11(Suppl. 2):S172-S180.
6. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin. Med. 2002, 2:45-53.
7. Rapaport E. Experimental cancer therapy in mice by adenine nucleotides. Eur. J. Cancer Clin. Oncol. 1988, 24:1491-1497.
8. Rapaport E., Fishman R.F., Gercel C. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5′-triphosphate. Cancer Res. 1983, 43:4402-4406.
9. Rapaport E. Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J. Cell Physiol. 1983, 114:279-283.
10. Shabbir M., Thompson C., Jarmulowiczc M., Mikhailidis D., Burnstock G. Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo. Bju. Int. 2008, 102:108-112.
11. Wang M.X., Ren L.M., Shan B.E. Inhibitory effects of extracellular adenosine triphosphate on growth of esophageal carcinoma cells. World J. Gastroenterol. 2005, 11:5915-5919.
12. Calvert R.C., Shabbir M., Thompson C.S., Mikhailidis D.P., Morgan R.J., Burnstock G. Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells. Anticancer Res. 2004, 24:2853-2859.
13. Conigrave A.D., van der Weyden L., Holt L., Jiang L., Wilson P., Christopherson R.I., Morris M.B. Extracellular ATP-dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms. Biochem. Pharmacol. 2000, 60:1585-1591.
14. Vandewalle B., Hornez L., Revillion F., Lefebvre J. Effect of extracellular ATP on breast tumor cell growth, implication of intracellular calcium. Cancer Lett. 1994, 85:47-54.
15. Fang W.G., Pirnia F., Bang Y.J., Myers C.E., Trepel J.B. P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J. Clin. Invest. 1992, 89:191-196.
16. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 2006, 58:58-86.
17. Hatta Y., Takahashi M., Enomoto Y., Takahashi N., Sawada U., Horie T. Adenosine triphosphate (ATP) enhances the antitumor effect of etoposide (VP16) in lung cancer cells. Oncol. Rep. 2004, 12:1139-1142.
18. Estrela J.M., Obrador E., Navarro J., Lasso D.L.V.M., Pellicer J.A. Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays. Nat. Med. 1995, 1:84-88.
19. Chen L., He H.Y., Li H.M., Zheng J., Heng W.J., You J.F., Fang W.G. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett. 2004, 215:239-247.
20. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987, 47:3239-3245.
21. Takaoka K., Kishimoto H., Segawa E., Hashitani S., Zushi Y., Noguchi K., Sakurai K., Urade M. Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA. Int. J. Oncol. 2006, 29:1095-1101.
22. Benard V., Bohl B.P., Bokoch G.M. Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J. Biol. Chem. 1999, 274:13198-13204.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using Real-Time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
24. Heasman S.J., Ridley A.J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 2008, 9:690-701.
25. White N., Burnstock G. P2 receptors and cancer. Trends Pharmacol. Sci. 2006, 27:211-217.
26. Agteresch H.J., Burgers S.A., van der Gaast A., Wilson J.H., Dagnelie P.C. Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients. Anticancer Drugs 2003, 14:639-644.
27. Leij-Halfwerk S., Agteresch H.J., Sijens P.E., Dagnelie P.C. Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo 31P magnetic resonance spectroscopy study. Hepatology 2002, 35:421-424.
28. Agteresch H.J., Dagnelie P.C., van der Gaast A., Stijnen T., Wilson J.H. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 2000, 92:321-328.
29. Agteresch H.J., Leij-Halfwerk S., Van Den Berg J.W., Hordijk-Luijk C.H., Wilson J.H., Dagnelie P.C. Effects of ATP infusion on glucose turnover and gluconeogenesis in patients with advanced non-small-cell lung cancer. Clin. Sci. (Lond) 2000, 98:689-695.
30. Haskell C.M., Mendoza E., Pisters K.M., Fossella F.V., Figlin R.A. Phase II study of intravenous adenosine 5′-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer. Invest. New Drugs 1998, 16:81-85.
31. Myrtek D., Idzko M. Chemotactic activity of extracellular nucleotides on human immune cells. Purinergic Signal. 2007, 3:5-11.
32. La Sala A., Sebastiani S., Ferrari D., Di Virgilio F., Idzko M., Norgauer J., Girolomoni G. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 2002, 99:1715-1722.
33. Verghese M.W., Kneisler T.B., Boucheron J.A. P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J. Biol. Chem. 1996, 271:15597-15601.
34. Mattila P.K., Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat. Rev. Mol. Cell. Biol. 2008, 9:446-454.
35. Ellenbroek S.I., Collard J.G. Rho GTPases: functions and association with cancer. Clin. Exp. Metast. 2007, 24:657-672.
36. Hall A. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 2005, 33:891-895.
37. Aspenstrom P., Fransson A., Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem. J. 2004, 377:327-337.
38. Ellis S., Mellor H. The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements. Curr. Biol. 2000, 10:1387-1390.
39. Chang S.J., Wang T.Y., Lee Y.H., Tai C.J. Extracellular ATP activates nuclear translocation of ERK1/2 leading to the induction of matrix metalloproteinases expression in human endometrial stromal cells. J. Endocrinol. 2007, 193:393-404.
40. Robinson W.R., Douillet C.D., Milano P.M., Boucher R.C., Patterson C., Rich P.B. ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1988-1996.
41. Gu B.J., Wiley J.S. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 2006, 107:4946-4953.
42. Decock J., Paridaens R., Cufer T. Proteases and metastasis: clinical relevance nowadays?. Curr. Opin. Oncol. 2005, 17:545-550.